Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 22901-22950 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06303505
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
PHASE1/PHASE2
Recruiting
100 participants
Started: Jun 12, 2024 · Completed: Jan 31, 2027
2 conditions
1 sponsor
12 locations
NCT06294028
International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease with Minimally Impaired Ejection Fraction
NA
Recruiting
268 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT06843928
The Adjunctive Effect of a Titanium Brush in the Non-Surgical Treatment of Peri-Implantitis
NA
Recruiting
36 participants
Started: Jun 12, 2024 · Completed: Jul 16, 2026
3 conditions
1 sponsor
1 location
NCT06409702
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
PHASE4
Recruiting
59 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2027
4 conditions
1 sponsor
1 location
NCT06581744
Non Invasive Imaging Methods for Detecting PA:a Clinical PET Study of 18F-Pentixather
NA
Recruiting
20 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06461000
EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
N/A
Recruiting
1,000 participants
Started: Jun 12, 2024 · Completed: Jun 12, 2029
2 conditions
1 sponsor
1 location
NCT06375564
Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression
PHASE1
Recruiting
20 participants
Started: Jun 12, 2024 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT06382168
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2
Recruiting
39 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
4 locations
NCT06408181
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
PHASE3
Recruiting
1,150 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2029
2 conditions
2 sponsors
1 location
NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
EARLY_PHASE1
Recruiting
24 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT06414135
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
PHASE1
Recruiting
6 participants
Started: Jun 12, 2024 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT06624241
Effectiveness of SRP+ Lipo-curcumin Gel for the Treatment of Stage III Periodontitis.
NA
Recruiting
40 participants
Started: Jun 12, 2024 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT06405347
The M-Well Inpatient Whole Health Bundle
NA
Recruiting
900 participants
Started: Jun 12, 2024 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT06136728
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
PHASE4
Recruiting
48 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04546685
"Virtual 1-Session Spanish Empowered Relief Group Intervention for Chronic Pain"
NA
Recruiting
110 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT07034105
Spatiotemporal Gait Parameters of Healthy and Stroke Patients During Overground, Treadmill, and Body Weight Supported Treadmill Walking
NA
Recruiting
25 participants
Started: Jun 12, 2024 · Completed: Feb 11, 2026
1 condition
2 sponsors
1 location
NCT05422690
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
PHASE2
Recruiting
16 participants
Started: Jun 12, 2024 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT06813365
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
PHASE1
Recruiting
76 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT06439589
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
88 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT06427629
Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device
NA
Recruiting
148 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06435351
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
EARLY_PHASE1
Recruiting
16 participants
Started: Jun 12, 2024 · Completed: May 31, 2029
2 conditions
1 sponsor
1 location
NCT06788821
Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology
N/A
Recruiting
440 participants
Started: Jun 12, 2024 · Completed: Mar 1, 2026
1 condition
1 sponsor
2 locations
NCT06769893
A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging
NA
Recruiting
60 participants
Started: Jun 12, 2024 · Completed: Nov 7, 2025
1 condition
1 sponsor
1 location
NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
PHASE2
Recruiting
252 participants
Started: Jun 12, 2024 · Completed: Dec 30, 2025
3 conditions
1 sponsor
1 location
NCT06673407
Group Exposure Workshops for Socially Anxious Undergraduates
NA
Recruiting
200 participants
Started: Jun 12, 2024 · Completed: Oct 1, 2025
4 conditions
1 sponsor
1 location
NCT06389136
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
PHASE3
Recruiting
200 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2027
1 condition
1 sponsor
96 locations
NCT06255392
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
PHASE3
Recruiting
200 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2031
2 conditions
1 sponsor
1 location
NCT06373328
Post Pandemic Pneumococcal Carriage Among Children and Adults
N/A
Recruiting
900 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT06405516
Platelet Function After Cardiac Surgery.
NA
Recruiting
40 participants
Started: Jun 12, 2024 · Completed: Jan 1, 2026
1 condition
3 sponsors
1 location
NCT06173154
Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID)
NA
Recruiting
76 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06355271
Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery
NA
Recruiting
63 participants
Started: Jun 12, 2024 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT06111417
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners
N/A
Recruiting
150 participants
Started: Jun 12, 2024 · Completed: Sep 12, 2026
1 condition
1 sponsor
2 locations
NCT06350786
Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer Pain
NA
Recruiting
86 participants
Started: Jun 12, 2024 · Completed: Jul 31, 2026
1 condition
3 sponsors
1 location
NCT06320054
Preventing Obstetric Complications With Dietary Intervention
NA
Recruiting
100 participants
Started: Jun 12, 2024 · Completed: Aug 31, 2025
4 conditions
3 sponsors
1 location
NCT06342037
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
PHASE2
Recruiting
60 participants
Started: Jun 12, 2024 · Completed: Apr 1, 2030
1 condition
2 sponsors
1 location
NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
PHASE4
Recruiting
65 participants
Started: Jun 12, 2024 · Completed: Jul 9, 2027
1 condition
1 sponsor
50 locations
NCT06655662
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
PHASE1
Recruiting
8 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
PHASE1/PHASE2
Recruiting
12 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2031
1 condition
1 sponsor
18 locations
NCT06723067
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
NA
Recruiting
30 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06509126
Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
PHASE3
Recruiting
500 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT06528717
The Role of Maintaining External Carotid Artery Flow in Graft Interposition After Carotid Endarterectomy
N/A
Recruiting
250 participants
Started: Jun 12, 2024 · Completed: Dec 30, 2024
3 conditions
1 sponsor
1 location
NCT06525532
Clinical-MRI Evaluation in Patients Undergoing Subtalar Arthrorisis With Reabsorbable Endorthesis Implant in PLLA
N/A
Recruiting
35 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06495528
Bliss DTx Assessment During Course Care Including Port-A-Catheter Setting
NA
Recruiting
318 participants
Started: Jun 12, 2024 · Completed: May 12, 2025
1 condition
1 sponsor
1 location
NCT06452238
External Oblique Intercostal Plane Block Versus Transversus Abdominis Plane Block for Postoperative Analgesia in Adult Patients Undergoing Open Nephrectomy
NA
Recruiting
40 participants
Started: Jun 12, 2024 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT06409351
Multi-modal Training Program to Promote Physical Activity After Stroke
NA
Recruiting
120 participants
Started: Jun 11, 2024 · Completed: Mar 31, 2026
2 conditions
3 sponsors
1 location
NCT05540548
Contribution of the Podiatrist-Posturologist in the Evaluation of the Link Between the Stabilometric Parameters and the Pain Felt in Patients With Chronic Low Back Pain
N/A
Recruiting
139 participants
Started: Jun 11, 2024 · Completed: Jun 11, 2026
1 condition
1 sponsor
1 location
NCT06192797
Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2
Recruiting
36 participants
Started: Jun 11, 2024 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT06411626
Home Reported Outcomes in PNH
N/A
Recruiting
128 participants
Started: Jun 11, 2024 · Completed: Jun 15, 2026
1 condition
1 sponsor
1 location
NCT06308965
Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?
NA
Recruiting
300 participants
Started: Jun 11, 2024 · Completed: Mar 31, 2027
2 conditions
1 sponsor
1 location
NCT06491043
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
PHASE2
Recruiting
90 participants
Started: Jun 11, 2024 · Completed: Dec 30, 2027
1 condition
1 sponsor
2 locations
Previous
1
More pages
456
457
458
459
460
461
462
More pages
1333
Next